It’s been a tough year for makers of prescription digital therapeutics, many of whom have had to drastically cut staff—or even, in the case of Pear Therapeutics, completely shut down—to conserve ...

A month after announcing it was seeking strategic alternatives, Akili Interactive, maker of a video game designed to treat ADHD, said it will go private in a merger with Virtual Therapeutics. The deal ...

The team at Akili describes its ethos on its website as “establishing a new era of cognitive medicine.” The company writes it “[believes] effective medicine can also be fun and engaging [by] creating ...

Akili Interactive, which in 2020 made waves by receiving Food and Drug Administration clearance for its video game that improves symptoms of ADHD in children, on Wednesday announced it would reorient ...

Enter Akili Interactive. After struggling with vying for insurance coverage of EndeavorRX, a video game-based treatment for ADHD; pivoting away from the PDT model, and cutting 40% of its staff in ...

Following its recent $30 million fundraise to advance its video game platform for neurological conditions such as attention deficit hyperactivity disorder and Alzheimer’s disease, Akili Interactive ...

NAIROBI, Kenya—While the pandemic appears to be in the rearview mirror, it clearly disrupted normal operations and workflows of broadcasters and media enterprises around the world. Those media ...